---
category: news
title: "Alchemab Announces Publication of AntiBERTa, an Antibody-Specific Machine Learning Model with Multiple Applications"
excerpt: "Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies and immune repertoire-based patient stratification tools, today announced the publication of research demonstrating the potential of AntiBERTa (Antibody-specific Bi-directional Encoder Representation and Transformers),"
publishedDateTime: 2022-05-19T11:02:00Z
originalUrl: "https://www.joplinglobe.com/region/national_business/alchemab-announces-publication-of-antiberta-an-antibody-specific-machine-learning-model-with-multiple-applications/article_da6f3650-aed7-5f65-9195-14ab79557d5c.html"
webUrl: "https://www.joplinglobe.com/region/national_business/alchemab-announces-publication-of-antiberta-an-antibody-specific-machine-learning-model-with-multiple-applications/article_da6f3650-aed7-5f65-9195-14ab79557d5c.html"
type: article
quality: 17
heat: 17
published: false

provider:
  name: Joplin Globe
  domain: joplinglobe.com

topics:
  - Machine Learning
  - AI

images:
  - url: "https://static.cnhionline.com/ksherman/images/rtj_ad.gif"
    width: 300
    height: 250
    isCached: true

secured: "utGO1M7nipTrf5KZnPh5ffvWPH52Vr0cLz1xNGudQqXn8eXgrsaH50yfrF9Nd3TJgenHe5y+BmyWZi6BNDz9aR833y+x7HBxAaLqb4yp86BLLwDwNnXTvN0V8T21wWj+9Ib9ZqQb9JtUksQUi95mgblRVEu7M/dwnbQzQg91IoW+TB/c3koJF1rdFk6OIDQ7Dxaxe+aq6Qi+qz5h2nRuaNJ8TMGBQNW7j6+A2nIQ1zEP4nZWCFeZTxzLWgqCf0NhaeBjb9mEQOC3HwgCNwWEkE5g37gUyjmUAUWZqmRDI1hZCICbn8PCf7wyFnRQQgtEz+leCri+fJ7hLPak+zc17c937J+J9c9LwsuobdfyJXu78dPd+BQiGp2guPlxjDKSAaemQiIt63mPTMVXp5IY3TFb9QWMFlN9E5CN///AjR+enT0o5P45AO72qxQBn7iFtGaksLiPwK4DR6yvvyoAEu84ohI0a1iBP/4ax5knHyp4EXJpThklImrsEd0WkvNOLiHPWwIkoT2T4Qko7gU1PQ==;/ZxpOO+vW8cZX3vfUzxmDw=="
---

